According to the latest report by IMARC Group, titled "Glaucoma Therapeutics Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025," the global glaucoma therapeutics market grew at a CAGR of around 4% during 2014-2019 and expects the market to continue its moderate growth during the next five years.Glaucoma is an ocular disorder that damages the optic nerve of the patient. The structural changes in the optic nerves are usually caused by the abnormally high intraocular pressure (IOP) due to the extra build-up of fluid in the front part of the eyes. This condition can often lead to vision loss and permanent blindness in progressive cases. Numerous medications and therapies are prescribed to patients with glaucoma in order to avoid complete vision loss. Eye drops that belong to the class of beta-blockers, alpha agonists, prostaglandins and cholinergic are usually prescribed to reduce the production of fluid in the eyes. These drops can then be followed by conventional or laser surgeries for effective results. In several cases, a combination of both approaches is utilized for the treatment of glaucoma.
Global Glaucoma Therapeutics Market Trends:
The market is primarily driven by the increasing occurrence of glaucoma on the global level. This can be attributed to the rising number of patients who have diabetes due to their shifting lifestyle patterns and a lack of physical activities.
Request Free Sample Report: https://www.imarcgroup.com/glaucoma-therapeutics-market/requestsample
Global Glaucoma Therapeutics Market 2020-2025 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Aerie Pharmaceuticals Inc., Allergan Plc, Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
The report has segmented the market on region, drug class, indication and end user.
Breakup by Drug Class:
Prostaglandin Analogs
Beta Blockers
Alpha Adrenergic Agonists
Carbonic Anhydrase Inhibitors
Combination Drugs
Others
Breakup by Indication:
Open Angle Glaucoma
Angle Closure Glaucoma
Others
Breakup by End User:
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Others
Breakup by Region:
North America:( United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico,Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/glaucoma-therapeutics-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact Us:
Company Name: IMARC Group
Email: sales@imarcgroup.com
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group